Statements (50)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:healthcare_organization
|
| gptkbp:can_lead_to |
liver failure
metastasis |
| gptkbp:caused_by |
cirrhosis
chronic hepatitis C infection aflatoxin exposure chronic hepatitis B infection |
| https://www.w3.org/2000/01/rdf-schema#label |
primary liver cancer
|
| gptkbp:is_associated_with |
gptkb:Company
alcohol consumption obesity nonalcoholic fatty liver disease |
| gptkbp:is_characterized_by |
ascites
tumor formation portal hypertension increased liver enzymes abnormal liver cells |
| gptkbp:is_often_used_in |
men
older adults people with liver disease people in Asia and Africa |
| gptkbp:is_part_of |
liver cancer category
|
| gptkbp:is_protected_by |
maintaining a healthy weight
treatment of hepatitis C vaccination against hepatitis B avoiding alcohol abuse |
| gptkbp:is_related_to |
palliative care
supportive care liver transplantation |
| gptkbp:is_studied_in |
clinical trials
|
| gptkbp:scientific_classification |
gptkb:hepatocellular_carcinoma
gptkb:cholangiocarcinoma mixed hepatocellular-cholangiocarcinoma |
| gptkbp:screenings |
gptkb:MRI
CT scan ultrasound |
| gptkbp:social_responsibility |
biopsy
imaging tests poor prognosis |
| gptkbp:symptoms |
nausea
weight loss abdominal pain jaundice loss of appetite |
| gptkbp:treatment |
gptkb:hospital
radiation therapy chemotherapy targeted therapy |
| gptkbp:bfsParent |
gptkb:vascular_endothelial_growth_factor
|
| gptkbp:bfsLayer |
5
|